eli lilly and company zepbound - Search News

News

Eli Lilly Vows to Make Weight-Loss Pill in U.S.

CBS News on MSN · 23h

Eli Lilly says GLP-1 pill for diabetes and weight loss effective in study, plans to seek FDA approval

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for diabetes and weight loss.

USA TODAY on MSN · 1d

Eli Lilly announces trial results of new weight loss, diabetes pill; stock booms

Eli Lilly announced the results of a clinical trial for its new pill, which the company said causes nearly 8% weight loss at certain dosages.

Insider on MSN · 1d

Eli Lilly finds its weight-loss pill works just as well as Ozempic — and investors are loving it

Eli Lilly shares are now positive for the year, up 10% since the start of January.

20h

Everything to know about the new weight loss pill that works as well as Ozempic — and when you can get it

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

24/7 Wall St.19h

Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2025-2030 (April 2025)

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.

1d

Eli Lilly: Cementing Its GLP-1 Empire With Orforglipron's Promising Phase 3 Results

Eli Lilly's oral GLP-1 drug orforglipron showed strong Phase 3 results with 7.9% weight loss and good tolerability, ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results